nach oben

Graefe's Archive for Clinical and Experimental Ophthalmology

18.05.2024 | Retinal Disorders

Prevalence of Age-Related Macular Degeneration in Patients with Chronic Exposure to P2X7R Inhibitors

verfasst von: Kwang Min Woo, M. Abdallah Mahrous, Donald J. D’Amico, Szilard Kiss, Kyle D. Kovacs

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology

Einloggen, um Zugang zu erhalten

Abstract

Purpose

P2X7 receptor (P2X7R) is a purinergic cation channel whose activation has been linked with age-related macular degeneration (ARMD). Several nucleoside reverse transcriptase inhibitors, zidovudine (AZT), lamivudine (3TC) and abacavir (ABC), have been shown to inhibit P2X7R and improve outcomes in animal models of ARMD. Our aim is to investigate the association between chronic AZT, 3TC, and ABC therapy and ARMD in a clinical setting.

Methods

This is a retrospective cohort study comparing 445 patients with HIV and confirmed usage of AZT, 3TC, and ABC against 200 patients with HIV without usage of AZT, 3TC, and ABC and 445 non-HIV infected patients. Fundus examination and spectral domain optical coherence tomography (SD-ODT) were used to measure prevalence of early-intermediate stage ARMD, geographic atrophy, and exudative ARMD.

Results

There was no statistically significant difference in the prevalence of early-intermediate stage ARMD between the HIV infected patients with a history of AZT, 3TC, and ABC use and the HIV infected patients without AZT, 3TC, and ABC use (p = 0.887). There was also no statistically significant difference in the prevalence of geographical atrophy (p = 0.062) and exudative AMD (p > 0.999) between the HIV infected patients with a history of AZT, 3TC, and ABC use and non-HIV infected patients.

Conclusion

We did not find an effect of P2X7R inhibiting antiretrovirals usage on early-intermediate stage ARMD, geographical atrophy, or exudative ARMD. Studies with larger cohort and more rigorous medication history are needed to assess the effects on geographical atrophy or exudative ARMD.

Mitchell P, Liew G, Gopinath B, Wong TY (2018) Age-related macular degeneration. Lancet 392(10153):1147–1159. https://doi.org/10.1016/s0140-6736(18)31550-2CrossRefPubMed

Ambati J, Atkinson JP, Gelfand BD (2013) Immunology of age-related macular degeneration. Nat Rev Immunol 13(6):438–451. https://doi.org/10.1038/nri3459CrossRefPubMedPubMedCentral

Illes P, Müller CE, Jacobson KA et al (2021) Update of P2X receptor properties and their pharmacology: IUPHAR Review 30. Br J Pharmacol 178(3):489–514. https://doi.org/10.1111/bph.15299CrossRefPubMed

Yang D, Elner SG, Clark AJ, Hughes BA, Petty HR, Elner VM (2011) Activation of P2X receptors induces apoptosis in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 52(3):1522–1530. Published 2011 Mar 18. https://doi.org/10.1167/iovs.10-6172

Platania CBM, Drago F, Bucolo C (2022) The P2X7 receptor as a new pharmacological target for retinal diseases. Biochem Pharmacol 198:114942. https://doi.org/10.1016/j.bcp.2022.114942CrossRefPubMed

Yang D, Chen J (2014) The P2X7 Receptor in AMD. Austin J Clin Ophthalmol 1(3):1012. ISSN: 2381-9162

Kerur N, Hirano Y, Tarallo V et al (2013) TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy. Invest Ophthalmol Vis Sci 54(12):7395–7401. Published 2013 Nov 11. https://doi.org/10.1167/iovs.13-12500

Drysdale C, Park K, Vessey KA et al (2022) P2X7-mediated alteration of membrane fluidity is associated with the late stages of age-related macular degeneration. Purinergic Signal 18(4):469–479. https://doi.org/10.1007/s11302-022-09894-yCrossRefPubMedPubMedCentral

Fowler BJ, Gelfand BD, Kim Y et al (2014) Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity. Science 346(6212):1000–1003. https://doi.org/10.1126/science.1261754CrossRefPubMedPubMedCentral

10.

Mizutani T, Fowler BJ, Kim Y et al (2015) Nucleoside reverse transcriptase inhibitors suppress laser-induced choroidal neovascularization in mice. Invest Ophthalmol Vis Sci 56(12):7122–7129. https://doi.org/10.1167/iovs.15-17440CrossRefPubMedPubMedCentral

11.

Narendran S, Pereira F, Yerramothu P et al (2020) A clinical metabolite of azidothymidine inhibits experimental choroidal neovascularization and retinal pigmented epithelium degeneration. Invest Ophthalmol Vis Sci 61(10):4. https://doi.org/10.1167/iovs.61.10.4CrossRefPubMedPubMedCentral

12.

Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, Beta carotene, and Zinc for age-related macular degeneration and vision loss: AREDS report No. 8. Arch Ophthalmol 119(10):1417–1436. https://doi.org/10.1001/archopht.119.10.1417

13.

Coleman HR, Chan CC, Ferris FL III, Chew EY (2008) Age-related macular degeneration. Lancet 372(9652):1835–1845. https://doi.org/10.1016/s0140-6736(08)61759-6CrossRefPubMedPubMedCentral

14.

Jabs DA, Van Natta ML, Sezgin E, Pak JW, Danis R (2015) Studies of the ocular complications of AIDS research group. Prevalence of intermediate-stage age-related macular degeneration in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 159(6):1115-1122.e1. https://doi.org/10.1016/j.ajo.2015.01.037CrossRefPubMedPubMedCentral

15.

Klein R, Klein BE, Linton KL (1992) Prevalence of age-related maculopathy. The beaver dam eye study. Ophthalmology 99(6):933–943. https://doi.org/10.1016/s0161-6420(92)31871-8CrossRefPubMed

16.

Rim TH, Kawasaki R, Tham YC et al (2020) Prevalence and pattern of geographic atrophy in Asia: The Asian eye epidemiology consortium. Ophthalmology 127(10):1371–1381. https://doi.org/10.1016/j.ophtha.2020.04.019CrossRefPubMed

17.

Jabs DA, Van Natta ML, Pak JW, Danis RP, Hunt PW (2018) Association of retinal vascular caliber and age-related macular degeneration in patients with the acquired immunodeficiency syndrome. Invest Ophthalmol Vis Sci 59(2):904–908. https://doi.org/10.1167/iovs.17-23334CrossRefPubMedPubMedCentral

18.

Jabs DA, Van Natta ML, Schneider MF et al (2022) Association of elevated plasma inflammatory biomarker levels with age-related macular degeneration but not cataract in persons with AIDS. AIDS 36(2):177–184. https://doi.org/10.1097/qad.0000000000003104CrossRefPubMed

19.

Graziano F, Desdouits M, Garzetti L et al (2015) Extracellular ATP induces the rapid release of HIV-1 from virus containing compartments of human macrophages. Proc Natl Acad Sci U S A 112(25):E3265–E3273. https://doi.org/10.1073/pnas.1500656112CrossRefPubMedPubMedCentral

20.

Swartz TH, Dubyak GR, Chen BK (2015) Purinergic receptors: key mediators of HIV-1 infection and inflammation. Front Immunol 6:585. Published 2015 Nov 26. https://doi.org/10.3389/fimmu.2015.00585

21.

De Anda-Duran I, Kimbrough AD, Bazzano LA (2023) HIV and hypertension epidemiology. Curr Opin Cardiol 38(4):297–303. https://doi.org/10.1097/hco.0000000000001050CrossRefPubMed

22.

Noubissi EC, Katte JC, Sobngwi E (2018) Diabetes and HIV. Curr Diab Rep 18(11):125. Published 2018 Oct 8. https://doi.org/10.1007/s11892-018-1076-3

23.

Asfar T, Perez A, Shipman P et al (2021) National estimates of prevalence, time-trend, and correlates of smoking in US people living with HIV (NHANES 1999–2016). Nicotine Tob Res 23(8):1308–1317. https://doi.org/10.1093/ntr/ntaa277CrossRefPubMedPubMedCentral

24.

Chandramohan A, Stinnett SS, Petrowski JT et al (2016) Visual function measures in early and intermediate age-related macular degeneration. Retina 36(5):1021–1031. https://doi.org/10.1097/iae.0000000000001002CrossRefPubMedPubMedCentral

25.

Cassels NK, Wild JM, Margrain TH, Chong V, Acton JH (2018) The use of microperimetry in assessing visual function in age-related macular degeneration. Surv Ophthalmol 63(1):40–55. https://doi.org/10.1016/j.survophthal.2017.05.007CrossRefPubMed

26.

Gerber WM, Meyer D, Smit DP (2016) Ocular and cerebrospinal fluid penetration of antiretroviral agents. J Ocul Pharmacol Ther 32(7):476–481. https://doi.org/10.1089/jop.2015.0151CrossRefPubMed

Titel: Prevalence of Age-Related Macular Degeneration in Patients with Chronic Exposure to P2X7R Inhibitors
verfasst von: Kwang Min Woo
M. Abdallah Mahrous
Donald J. D’Amico
Szilard Kiss
Kyle D. Kovacs
Publikationsdatum: 18.05.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-024-06507-9

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Prevalence of Age-Related Macular Degeneration in Patients with Chronic Exposure to P2X7R Inhibitors

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

CME: Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

CME: Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde